| Title : Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis - Fan_2022_J.Neurol__ |
| Author(s) : Fan Z , Li Z , Zhao S , Chen Y , Su Y , Peng G , Luo B |
| Ref : Journal of Neurology , : , 2022 |
| Abstract : |
| PubMedSearch : Fan_2022_J.Neurol__ |
| PubMedID: 36562850 |
| Title : Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis - Fan_2022_J.Neurol__ |
| Author(s) : Fan Z , Li Z , Zhao S , Chen Y , Su Y , Peng G , Luo B |
| Ref : Journal of Neurology , : , 2022 |
| Abstract : |
| PubMedSearch : Fan_2022_J.Neurol__ |
| PubMedID: 36562850 |
| Title : Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis - Fan_2022_J.Neurol__ |
| Author(s) : Fan Z , Li Z , Zhao S , Chen Y , Su Y , Peng G , Luo B |
| Ref : Journal of Neurology , : , 2022 |
| Abstract : |
| PubMedSearch : Fan_2022_J.Neurol__ |
| PubMedID: 36562850 |
| Title : Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial - Xiao_2017_Age.Ageing__1 |
| Author(s) : Xiao S , Wang T , Ma X , Qin Y , Li X , Zhao Z , Liu X , Wang X , Xie H , Jiang Q , Sun L , Luo B , Shang L , Chen W , Bai Y , Tang M , He M , Wu L , Ma Q , Hou D , He J |
| Ref : Age Ageing , :1 , 2017 |
| Abstract : |
| PubMedSearch : Xiao_2017_Age.Ageing__1 |
| PubMedID: 28419192 |
| Title : Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial - Xiao_2017_Age.Ageing__1 |
| Author(s) : Xiao S , Wang T , Ma X , Qin Y , Li X , Zhao Z , Liu X , Wang X , Xie H , Jiang Q , Sun L , Luo B , Shang L , Chen W , Bai Y , Tang M , He M , Wu L , Ma Q , Hou D , He J |
| Ref : Age Ageing , :1 , 2017 |
| Abstract : |
| PubMedSearch : Xiao_2017_Age.Ageing__1 |
| PubMedID: 28419192 |
| Title : Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial - Xiao_2017_Age.Ageing__1 |
| Author(s) : Xiao S , Wang T , Ma X , Qin Y , Li X , Zhao Z , Liu X , Wang X , Xie H , Jiang Q , Sun L , Luo B , Shang L , Chen W , Bai Y , Tang M , He M , Wu L , Ma Q , Hou D , He J |
| Ref : Age Ageing , :1 , 2017 |
| Abstract : |
| PubMedSearch : Xiao_2017_Age.Ageing__1 |
| PubMedID: 28419192 |